ARTEMIS MED SERVICE LTD Valuation

ARTEMISMED · Healthcare · Current price ₹327.95

Full stock page
DocStoX fair value
₹200
low confidence
Current price
₹328
Upside
-39.1%
P/E ratio
50.2x
P/B ratio
5.8x
Verdict
Avoid
Model it yourself — Earnings Yield Calculator
Opens pre-filled with ARTEMIS MED SERVICE LTD's latest numbers.

Is ARTEMIS MED SERVICE LTD undervalued?

DocStoX estimates the fair value of ARTEMIS MED SERVICE LTD at ₹200 per share, versus the current market price of ₹328. That puts the stock about -39.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹59), Relative P/E (₹422), Graham floor (₹94), Analyst target (₹351). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹59 (bear) to ₹200 (base) to ₹422 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Valuation multiples

ARTEMIS MED SERVICE LTD trades at a P/E of 50.2x and a P/B of 5.8x, with a dividend yield of 0.1%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

Understand the ratios

More on ARTEMIS MED SERVICE LTD

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.